Selected research
Industry Research
Digital Therapeutics Platforms Industry Research Report 2026
Market perspective
The global Digital Therapeutics Platforms market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Therapeutics Platforms market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Therapeutics Platforms market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Therapeutics Platforms market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Therapeutics Platforms include Akili Interactive, DarioHealth, Teladoc Health, Voluntis, Sidekick Health, WellDoc, Talkspace, CogniFit and Tata Elxsi, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Therapeutics Platforms market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Therapeutics Platforms.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Therapeutics Platforms Market by Company
Akili Interactive
DarioHealth
Teladoc Health
Voluntis
Sidekick Health
WellDoc
Talkspace
CogniFit
Tata Elxsi
Mahalo Health
2Morrow
Omada Health
Click Therapeutics
Orexo
ResMed
Virta Health
Bifourmis
SilverCloud (Amwell)
Noom
Big Health
Kaia Health
Cognoa
Headspace Health
CureApp
Calm Health
Riva Health
Sweetch-Health
Lark Health
Vida Health
Mahana Therapeutics
Blue Note Therapeutics
Lyra Health
Modern Health
Canary Health
Virgin Pulse
Slanhealth
Best Covered
Dami and Xiaomi
WeiMai
Jianhai Tech
Digital Therapeutics Platforms Segment by Type
Chronic Disease Digital Therapeutics
Psychiatric Disorders Digital Therapeutics
Quit Smoking Digital Therapeutics
Sleep Disorders and Respiratory Diseases Digital Therapeutics
Others
Digital Therapeutics Platforms Segment by Application
Enterprise
Personal
Digital Therapeutics Platforms Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Therapeutics Platforms companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chronic Disease Digital Therapeutics
- Psychiatric Disorders Digital Therapeutics
- Quit Smoking Digital Therapeutics
- Sleep Disorders and Respiratory Diseases Digital Therapeutics
- Others
Applications
- Enterprise
- Personal
Companies covered
- Akili Interactive
- DarioHealth
- Teladoc Health
- Voluntis
- Sidekick Health
- WellDoc
- Talkspace
- CogniFit
- Tata Elxsi
- Mahalo Health
- 2Morrow
- Omada Health
- Click Therapeutics
- Orexo
- ResMed
- Virta Health
- Bifourmis
- SilverCloud (Amwell)
- Noom
- Big Health
- Kaia Health
- Cognoa
- Headspace Health
- CureApp
- Calm Health
- Riva Health
- Sweetch-Health
- Lark Health
- Vida Health
- Mahana Therapeutics
- Blue Note Therapeutics
- Lyra Health
- Modern Health
- Canary Health
- Virgin Pulse
- Slanhealth
- Best Covered
- Dami and Xiaomi
- WeiMai
- Jianhai Tech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Therapeutics Platforms by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Chronic Disease Digital Therapeutics
- 2.2.3 Psychiatric Disorders Digital Therapeutics
- 2.2.4 Quit Smoking Digital Therapeutics
- 2.2.5 Sleep Disorders and Respiratory Diseases Digital Therapeutics
- 2.2.6 Others
- 2.3 Digital Therapeutics Platforms by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Enterprise
- 2.3.3 Personal
- 2.4 Assumptions and Limitations
3 Digital Therapeutics Platforms Breakdown Data by Type
- 3.1 Global Digital Therapeutics Platforms Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Therapeutics Platforms Forecasted Market Size by Type (2027-2032)
4 Digital Therapeutics Platforms Breakdown Data by Application
- 4.1 Global Digital Therapeutics Platforms Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Therapeutics Platforms Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Therapeutics Platforms Market Perspective (2021-2032)
- 5.2 Global Digital Therapeutics Platforms Growth Trends by Region
- 5.2.1 Global Digital Therapeutics Platforms Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Therapeutics Platforms Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Therapeutics Platforms Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Therapeutics Platforms Market Dynamics
- 5.3.1 Digital Therapeutics Platforms Industry Trends
- 5.3.2 Digital Therapeutics Platforms Market Drivers
- 5.3.3 Digital Therapeutics Platforms Market Challenges
- 5.3.4 Digital Therapeutics Platforms Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Therapeutics Platforms Players by Revenue
- 6.1.1 Global Top Digital Therapeutics Platforms Players by Revenue (2021-2026)
- 6.1.2 Global Digital Therapeutics Platforms Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Therapeutics Platforms Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Therapeutics Platforms Head Office and Area Served
- 6.4 Global Digital Therapeutics Platforms Players, Product Type & Application
- 6.5 Global Digital Therapeutics Platforms Manufacturers Established Date
- 6.6 Global Digital Therapeutics Platforms Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Therapeutics Platforms Market Size (2021-2032)
- 7.2 North America Digital Therapeutics Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 7.4 North America Digital Therapeutics Platforms Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Therapeutics Platforms Market Size (2021-2032)
- 8.2 Europe Digital Therapeutics Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 8.4 Europe Digital Therapeutics Platforms Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Therapeutics Platforms Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Therapeutics Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Therapeutics Platforms Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Therapeutics Platforms Market Size (2021-2032)
- 10.2 South America Digital Therapeutics Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 10.4 South America Digital Therapeutics Platforms Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Therapeutics Platforms Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Therapeutics Platforms Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Akili Interactive
- 12.1.1 Akili Interactive Company Information
- 12.1.2 Akili Interactive Business Overview
- 12.1.3 Akili Interactive Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.1.4 Akili Interactive Digital Therapeutics Platforms Product Portfolio
- 12.1.5 Akili Interactive Recent Developments
- 12.2 DarioHealth
- 12.2.1 DarioHealth Company Information
- 12.2.2 DarioHealth Business Overview
- 12.2.3 DarioHealth Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.2.4 DarioHealth Digital Therapeutics Platforms Product Portfolio
- 12.2.5 DarioHealth Recent Developments
- 12.3 Teladoc Health
- 12.3.1 Teladoc Health Company Information
- 12.3.2 Teladoc Health Business Overview
- 12.3.3 Teladoc Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.3.4 Teladoc Health Digital Therapeutics Platforms Product Portfolio
- 12.3.5 Teladoc Health Recent Developments
- 12.4 Voluntis
- 12.4.1 Voluntis Company Information
- 12.4.2 Voluntis Business Overview
- 12.4.3 Voluntis Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.4.4 Voluntis Digital Therapeutics Platforms Product Portfolio
- 12.4.5 Voluntis Recent Developments
- 12.5 Sidekick Health
- 12.5.1 Sidekick Health Company Information
- 12.5.2 Sidekick Health Business Overview
- 12.5.3 Sidekick Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.5.4 Sidekick Health Digital Therapeutics Platforms Product Portfolio
- 12.5.5 Sidekick Health Recent Developments
- 12.6 WellDoc
- 12.6.1 WellDoc Company Information
- 12.6.2 WellDoc Business Overview
- 12.6.3 WellDoc Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.6.4 WellDoc Digital Therapeutics Platforms Product Portfolio
- 12.6.5 WellDoc Recent Developments
- 12.7 Talkspace
- 12.7.1 Talkspace Company Information
- 12.7.2 Talkspace Business Overview
- 12.7.3 Talkspace Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.7.4 Talkspace Digital Therapeutics Platforms Product Portfolio
- 12.7.5 Talkspace Recent Developments
- 12.8 CogniFit
- 12.8.1 CogniFit Company Information
- 12.8.2 CogniFit Business Overview
- 12.8.3 CogniFit Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.8.4 CogniFit Digital Therapeutics Platforms Product Portfolio
- 12.8.5 CogniFit Recent Developments
- 12.9 Tata Elxsi
- 12.9.1 Tata Elxsi Company Information
- 12.9.2 Tata Elxsi Business Overview
- 12.9.3 Tata Elxsi Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.9.4 Tata Elxsi Digital Therapeutics Platforms Product Portfolio
- 12.9.5 Tata Elxsi Recent Developments
- 12.10 Mahalo Health
- 12.10.1 Mahalo Health Company Information
- 12.10.2 Mahalo Health Business Overview
- 12.10.3 Mahalo Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.10.4 Mahalo Health Digital Therapeutics Platforms Product Portfolio
- 12.10.5 Mahalo Health Recent Developments
- 12.11 2Morrow
- 12.11.1 2Morrow Company Information
- 12.11.2 2Morrow Business Overview
- 12.11.3 2Morrow Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.11.4 2Morrow Digital Therapeutics Platforms Product Portfolio
- 12.11.5 2Morrow Recent Developments
- 12.12 Omada Health
- 12.12.1 Omada Health Company Information
- 12.12.2 Omada Health Business Overview
- 12.12.3 Omada Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.12.4 Omada Health Digital Therapeutics Platforms Product Portfolio
- 12.12.5 Omada Health Recent Developments
- 12.13 Click Therapeutics
- 12.13.1 Click Therapeutics Company Information
- 12.13.2 Click Therapeutics Business Overview
- 12.13.3 Click Therapeutics Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.13.4 Click Therapeutics Digital Therapeutics Platforms Product Portfolio
- 12.13.5 Click Therapeutics Recent Developments
- 12.14 Orexo
- 12.14.1 Orexo Company Information
- 12.14.2 Orexo Business Overview
- 12.14.3 Orexo Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.14.4 Orexo Digital Therapeutics Platforms Product Portfolio
- 12.14.5 Orexo Recent Developments
- 12.15 ResMed
- 12.15.1 ResMed Company Information
- 12.15.2 ResMed Business Overview
- 12.15.3 ResMed Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.15.4 ResMed Digital Therapeutics Platforms Product Portfolio
- 12.15.5 ResMed Recent Developments
- 12.16 Virta Health
- 12.16.1 Virta Health Company Information
- 12.16.2 Virta Health Business Overview
- 12.16.3 Virta Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.16.4 Virta Health Digital Therapeutics Platforms Product Portfolio
- 12.16.5 Virta Health Recent Developments
- 12.17 Bifourmis
- 12.17.1 Bifourmis Company Information
- 12.17.2 Bifourmis Business Overview
- 12.17.3 Bifourmis Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.17.4 Bifourmis Digital Therapeutics Platforms Product Portfolio
- 12.17.5 Bifourmis Recent Developments
- 12.18 SilverCloud (Amwell)
- 12.18.1 SilverCloud (Amwell) Company Information
- 12.18.2 SilverCloud (Amwell) Business Overview
- 12.18.3 SilverCloud (Amwell) Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.18.4 SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio
- 12.18.5 SilverCloud (Amwell) Recent Developments
- 12.19 Noom
- 12.19.1 Noom Company Information
- 12.19.2 Noom Business Overview
- 12.19.3 Noom Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.19.4 Noom Digital Therapeutics Platforms Product Portfolio
- 12.19.5 Noom Recent Developments
- 12.20 Big Health
- 12.20.1 Big Health Company Information
- 12.20.2 Big Health Business Overview
- 12.20.3 Big Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.20.4 Big Health Digital Therapeutics Platforms Product Portfolio
- 12.20.5 Big Health Recent Developments
- 12.21 Kaia Health
- 12.21.1 Kaia Health Company Information
- 12.21.2 Kaia Health Business Overview
- 12.21.3 Kaia Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.21.4 Kaia Health Digital Therapeutics Platforms Product Portfolio
- 12.21.5 Kaia Health Recent Developments
- 12.22 Cognoa
- 12.22.1 Cognoa Company Information
- 12.22.2 Cognoa Business Overview
- 12.22.3 Cognoa Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.22.4 Cognoa Digital Therapeutics Platforms Product Portfolio
- 12.22.5 Cognoa Recent Developments
- 12.23 Headspace Health
- 12.23.1 Headspace Health Company Information
- 12.23.2 Headspace Health Business Overview
- 12.23.3 Headspace Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.23.4 Headspace Health Digital Therapeutics Platforms Product Portfolio
- 12.23.5 Headspace Health Recent Developments
- 12.24 CureApp
- 12.24.1 CureApp Company Information
- 12.24.2 CureApp Business Overview
- 12.24.3 CureApp Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.24.4 CureApp Digital Therapeutics Platforms Product Portfolio
- 12.24.5 CureApp Recent Developments
- 12.25 Calm Health
- 12.25.1 Calm Health Company Information
- 12.25.2 Calm Health Business Overview
- 12.25.3 Calm Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.25.4 Calm Health Digital Therapeutics Platforms Product Portfolio
- 12.25.5 Calm Health Recent Developments
- 12.26 Riva Health
- 12.26.1 Riva Health Company Information
- 12.26.2 Riva Health Business Overview
- 12.26.3 Riva Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.26.4 Riva Health Digital Therapeutics Platforms Product Portfolio
- 12.26.5 Riva Health Recent Developments
- 12.27 Sweetch-Health
- 12.27.1 Sweetch-Health Company Information
- 12.27.2 Sweetch-Health Business Overview
- 12.27.3 Sweetch-Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.27.4 Sweetch-Health Digital Therapeutics Platforms Product Portfolio
- 12.27.5 Sweetch-Health Recent Developments
- 12.28 Lark Health
- 12.28.1 Lark Health Company Information
- 12.28.2 Lark Health Business Overview
- 12.28.3 Lark Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.28.4 Lark Health Digital Therapeutics Platforms Product Portfolio
- 12.28.5 Lark Health Recent Developments
- 12.29 Vida Health
- 12.29.1 Vida Health Company Information
- 12.29.2 Vida Health Business Overview
- 12.29.3 Vida Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.29.4 Vida Health Digital Therapeutics Platforms Product Portfolio
- 12.29.5 Vida Health Recent Developments
- 12.30 Mahana Therapeutics
- 12.30.1 Mahana Therapeutics Company Information
- 12.30.2 Mahana Therapeutics Business Overview
- 12.30.3 Mahana Therapeutics Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.30.4 Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio
- 12.30.5 Mahana Therapeutics Recent Developments
- 12.31 Blue Note Therapeutics
- 12.31.1 Blue Note Therapeutics Company Information
- 12.31.2 Blue Note Therapeutics Business Overview
- 12.31.3 Blue Note Therapeutics Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.31.4 Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio
- 12.31.5 Blue Note Therapeutics Recent Developments
- 12.32 Lyra Health
- 12.32.1 Lyra Health Company Information
- 12.32.2 Lyra Health Business Overview
- 12.32.3 Lyra Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.32.4 Lyra Health Digital Therapeutics Platforms Product Portfolio
- 12.32.5 Lyra Health Recent Developments
- 12.33 Modern Health
- 12.33.1 Modern Health Company Information
- 12.33.2 Modern Health Business Overview
- 12.33.3 Modern Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.33.4 Modern Health Digital Therapeutics Platforms Product Portfolio
- 12.33.5 Modern Health Recent Developments
- 12.34 Canary Health
- 12.34.1 Canary Health Company Information
- 12.34.2 Canary Health Business Overview
- 12.34.3 Canary Health Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.34.4 Canary Health Digital Therapeutics Platforms Product Portfolio
- 12.34.5 Canary Health Recent Developments
- 12.35 Virgin Pulse
- 12.35.1 Virgin Pulse Company Information
- 12.35.2 Virgin Pulse Business Overview
- 12.35.3 Virgin Pulse Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.35.4 Virgin Pulse Digital Therapeutics Platforms Product Portfolio
- 12.35.5 Virgin Pulse Recent Developments
- 12.36 Slanhealth
- 12.36.1 Slanhealth Company Information
- 12.36.2 Slanhealth Business Overview
- 12.36.3 Slanhealth Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.36.4 Slanhealth Digital Therapeutics Platforms Product Portfolio
- 12.36.5 Slanhealth Recent Developments
- 12.37 Best Covered
- 12.37.1 Best Covered Company Information
- 12.37.2 Best Covered Business Overview
- 12.37.3 Best Covered Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.37.4 Best Covered Digital Therapeutics Platforms Product Portfolio
- 12.37.5 Best Covered Recent Developments
- 12.38 Dami and Xiaomi
- 12.38.1 Dami and Xiaomi Company Information
- 12.38.2 Dami and Xiaomi Business Overview
- 12.38.3 Dami and Xiaomi Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.38.4 Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio
- 12.38.5 Dami and Xiaomi Recent Developments
- 12.39 WeiMai
- 12.39.1 WeiMai Company Information
- 12.39.2 WeiMai Business Overview
- 12.39.3 WeiMai Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.39.4 WeiMai Digital Therapeutics Platforms Product Portfolio
- 12.39.5 WeiMai Recent Developments
- 12.40 Jianhai Tech
- 12.40.1 Jianhai Tech Company Information
- 12.40.2 Jianhai Tech Business Overview
- 12.40.3 Jianhai Tech Revenue in Digital Therapeutics Platforms Business (2021-2026)
- 12.40.4 Jianhai Tech Digital Therapeutics Platforms Product Portfolio
- 12.40.5 Jianhai Tech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst